ホーム>>Peptides>>β-CGRP, human (Human β-CGRP)

β-CGRP, human (Human β-CGRP)

カタログ番号GC33595

β-CGRP、ヒト(Human β-CGRP)はカルシトニンペプチドの一種であり、カルシトニン受容体様受容体(CRLR)とレセプター活性修飾タンパク質(RAMP)の複合体を介して作用し、細胞内でのCRLR/RAMP1およびCRLR/RAMP2に対するIC50はそれぞれ1 nMおよび300 nMです。

Products are for research use only. Not for human use. We do not sell to patients.

β-CGRP, human (Human β-CGRP) 化学構造

Cas No.: 101462-82-2

サイズ 価格 在庫数 個数
500μg
$166.00
在庫あり
1mg
$285.00
在庫あり
5mg
$1,011.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

β-CGRP, human is one of calcitonin peptides, acts via the complex of calcitonin-receptor-like receptor (CRLR) and receptor-activity-modifying protein (RAMP), with IC50s of 1 nM and 300 nM for CRLR/RAMP1 and CRLR/RAMP2 in cells.

β-CGRP, human is one of calcitonin peptides, acts via complex of calcitonin-receptor-like receptor (CRLR) and receptor-activity-modifying protein (RAMP), with IC50s of 1 nM in both SK-N-MC and Swiss 3T3 cells express CRLR and RAMP1, and 130 nM and 300 nM in NG108-15 and HEK293T cells expressing CRLR and RAMP2[1]. CGRP is a potent vasodilator and also shows pro- and -anti-inflammatory activity[2].

[1]. McLatchie LM, et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 1998 May 28;393(6683):333-9. [2]. Russell FA, et al. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014 Oct;94(4):1099-142.

レビュー

Review for β-CGRP, human (Human β-CGRP)

Average Rating: 5 ★★★★★ (Based on Reviews and 32 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for β-CGRP, human (Human β-CGRP)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.